Million-Dollar Fine for Animal Experimentation Violations: Primate Center Foundation and Caucaseco Research Center Face Record Penalties
On social networks, and in communities in general, more and more attention is paid to cases of animal abuse, or cases of experimentation with specieswhether for scientific or cosmetic topics. Precisely, in recent days it became known about a million-dollar fine for two research entities for testing vaccines in the first place. You may be … Read more
The post Million-Dollar Fine for Animal Experimentation Violations: Primate Center Foundation and Caucaseco Research Center Face Record Penalties appeared first on World Today News.
Guide for the use of stoves and braziers at home · Healthy Housing
2024-01-30 12:04:36 We live in times in which heating costs have skyrocketed, causing many homes to…
The post Guide for the use of stoves and braziers at home · Healthy Housing appeared first on TIme News.
Guide for the use of stoves and braziers at home · Healthy Housing
In shape with Aurora Ruffino: “I only eat if I’m hungry, like newborns”
Aurora Ruffino, 34 years old, actress, already protagonist of the film “White like milk, red like blood”…
The post In shape with Aurora Ruffino: “I only eat if I’m hungry, like newborns” appeared first on Breaking Latest News.
In shape with Aurora Ruffino: “I only eat if I’m hungry, like newborns”
CHA Biotech’s Third-Generation Hepatitis B Vaccine Shows Strong Results in Phase 1 Clinical Trial
CHA Vaccine Research Institute (CEO Yeom Jeong-seon), an affiliate of CHA Biotech, announced the Phase 1 Clinical Trial Result Report (CSR) results (key indicators) of China’s preventive hepatitis B vaccine on the 30th. third generation ‘CVI -HBV-002’. . The CHA Vaccine Research Institute received IND approval for national phase 1 clinical trials of the third-generation […]
The post CHA Biotech’s Third-Generation Hepatitis B Vaccine Shows Strong Results in Phase 1 Clinical Trial appeared first on News Directory 3.
CHA Biotech’s Third-Generation Hepatitis B Vaccine Shows Strong Results in Phase 1 Clinical Trial